| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |